HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Longterm complete remission of AL-amyloid-related nephrotic syndrome.

Abstract
We describe a 59-year-old man with nephrotic syndrome that was diagnosed as suspected minimal change nephrotic syndrome by the routine examination of renal tissues at first biopsy, because renal histology showed segmental mild mesangial expansion with argyrophilic staining and partial foot process fusion without any deposition. Prednisolone therapy induced complete remission of nephrotic syndrome. Relapse occurred after 4 years of complete remission, and the second renal biopsy revealed amyloid light-chain (AL)-amyloidosis. Re-examination of the first biopsy tissues by Congo red staining confirmed a small amount of amyloid deposition in the mesangial areas although the mesangial areas showed argyrophilic staining, which is atypical for amyloid deposition. This case raises a caution that even when renal histology is not suggestive of amyloidosis and prednisolone therapy is very effective, when a renal histology diagnosis is not confirmed, the clinician should suspect amyloidosis and should, at least, undertake Congo red staining to definitively rule out amyloidosis.
AuthorsYoshihide Fujigaki, Satoru Takahashi, Katsuhiko Yonemura, Hiroyuki Suzuki, Akashi Togawa, Hirotaka Fukasawa, Tetsuo Goto, Tatsuo Yamamoto, Akira Hishida
JournalClinical and experimental nephrology (Clin Exp Nephrol) Vol. 7 Issue 3 Pg. 250-3 (Sep 2003) ISSN: 1342-1751 [Print] Japan
PMID14586724 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Coloring Agents
  • Congo Red
Topics
  • Amyloidosis (complications, pathology)
  • Coloring Agents
  • Congo Red
  • Humans
  • Male
  • Middle Aged
  • Nephrotic Syndrome (etiology, pathology)
  • Recurrence
  • Remission, Spontaneous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: